DIFFUSION-WEIGHTED MRI AND PROTON MAGNETIC RESONANCE SPECTROSCOPY IN THE DIAGNOSIS AND EVALUATION OF THE EFFECTIVENESS OF CHEMORADIOTHERAPY OF HEAD AND NECK TUMORS (THE LITERATURE REVIEW)
https://doi.org/10.18705/2311-4495-2019-6-1-17-26
Abstract
The review presents an analysis of the modern literature on the diagnosis of head and neck tumors, as well as the study of their structural and functional features based on the use of magnetic resonance imaging technologies. The possibilities of diffusion-weighted MRI and proton magnetic resonance spectroscopy in the diagnosis, planning and evaluation of the effectiveness of radiation and sandwich therapy of head and neck cancer are presented in the review.
About the Authors
M. D. Semenova
Granov Russian Research Center of Radiology and Surgical Technologies
Semenova Maria D., Assistant Professor, Department of Radiology, Surgery and Oncology
Semenova Maria D., Assistant Professor, Department of Radiology, Surgery and Oncology
V. P. Sokurenko
Granov Russian Research Center of Radiology and Surgical Technologies
Sokurenko Valentina P., MD, PhD, Head of the Radiological Department No. 4
Sokurenko Valentina P., MD, PhD, Head of the Radiological Department No. 4
A. A. Stanzhevskiy
Granov Russian Research Center of Radiology and Surgical Technologies;
Almazov National Medical Research Center
Russian Federation
Russian Federation
Stanzhevskiy Andrey A., MD, PhD, Deputy Director for Scientific Work;
Professor, Department of Radiation Diagnostics and Medical Imaging, Institute of Medical Education
V. F. Mus
Granov Russian Research Center of Radiology and Surgical Technologies
Mus Viktor F., Chief Researcher of the Department of Radiation and Combined Methods of Treating Tumor Diseases
Mus Viktor F., Chief Researcher of the Department of Radiation and Combined Methods of Treating Tumor Diseases
References
1. Yan K, Agrawal N, Gooi Z. Head and Neck Masses. Med Clin North Am. 2018 Nov;102(6):1013-1025. doi: 10.1016/j.mcna2.
2. Curado MP, Boyle P Epidemiology of head and neck squamous cell carcinoma not related to tobacco or alcohol. Curr Opin Oncol 2013;25(3):229–34.
3. Dai YL, King AD State of the art MRI in head and neck cancer Clin Radiol. 2018 Jan;73(1):45-59. doi: 10.1016/j.crad.2017.05.020. Epub 2017 Jun 24.
4. Ahn SJ, Choi SH, Kim YJ, et al. Histogram analysis of apparent diffusion coefficient map of standard and high B-value diffusion MR imaging in head and neck squamous cell carcinoma: a correlation study with histological grade. Acad Radiol 2012;19(10):1233-40.
5. Hwang I, Choi SH, Kim YJ, et al. Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging. AJNR Am J Neuroradiol 2013;34(12):2343-8.
6. Yun TJ, Kim JH, Kim KH, et al. Head and neck squamous cell carcinoma: differentiation of histologic grade with standard- and high-b-value diffusion-weighted MRI. Head Neck 2013;35(5):626-31.
7. Ryoo I, Kim JH, Choi SH, et al. Squamous cell carcinoma of the head and neck: comparison of diffusion-weighted MRI at b-values of 1,000 and 2,000 s/mm2 to predict response to induction chemotherapy. Magn Reson Med Sci 2015;14(4):337-45.
8. Acampora A, Manzo G, Fenza G, et al. High b-value diffusion MRI to differentiate recurrent tumors from posttreatment changes in head and neck squamous cell carcinoma: a single center prospective study. Biomed Res Int 2016;2016:2865169
9. Wang J, Takashima S, Takayama F, et al. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology 2001;220(3):621-30.
10. Thoeny HC, De Keyzer F, King AD. Diffusion-weighted MR imaging in the head and neck. Radiology 2012;263(1):19-32.
11. Abdel Razek AA, Nada N. Role of diffusion-weighted MRI in differentiation of masticator space malignancy from infection. Dentomaxillofac Radiol 2013;42(4):20120183.
12. Koc O, Paksoy Y, Erayman I, et al. Role of diffusion weighted MR in the discrimination diagnosis of the cystic and/or necrotic head and neck lesions. Eur J Radiol 2007;62(2):205-13.
13. King AD, Yeung DK, Ahuja AT, et al. Salivary gland tumors at in vivo proton MR spectroscopy. Radiology 2005;237(2):563-9.
14. Salama AA, El-Barbary AH, Mlees MA, et al. Value of apparent diffusion coefficient and magnetic resonance spectroscopy in the identification of various pathological subtypes of parotid gland tumors. Egypt J Radiol Nucl Med 2015;46(1):45-52.
15. Chen L, Xu J, Bao J, et al. Diffusion-weighted MRI in differentiating malignant from benign thyroid nodules: a meta-analysis. BMJ Open 2016;6(1):008413.
16. Maeda M, Kato H, Sakuma H, et al. Usefulness of the apparent diffusion coefficient in line scan diffusion-weighted imaging for distinguishing between squamous cell carcinomas and malignant lymphomas of the head and neck. AJNR 2005;26(5):1186-92.
17. Ichikawa Y, Sumi M, Sasaki M, et al. Efficacy of diffusion-weighted imaging for the differentiation between lymphomas and carcinomas of the nasopharynx and oropharynx: correlations of apparent diffusion coefficients and histologic features. AJNR Am J Neuroradiol 2012;33(4):761-6.
18. Sumi M, Nakamura T. Head and neck tumours: combined MRI assessment based on IVIM and TIC analyses for the differentiation of tumors of different histological types. Eur Radiol 2014;24(1):223-31
19. Kato H, Kanematsu M, Kato Z, et al. Necrotic cervical nodes: usefulness of diffusion-weighted MR imaging in the differentiation of suppurative lymphadenitis from malignancy. Eur J Radiol 2013;82(1):28-35.
20. Zhang Y, Chen J, Shen J, et al. Apparent diffusion coefficient values of necrotic and solid portion of lymph nodes: differential diagnostic value in cervical lymphadenopathy. Clin Radiol 2013;68(3):224-31.
21. Holzapfel K, Duetsch S, Fauser C, et al. Value of diffusion-weighted MR imaging in the differentiation between benign and malignant cervical lymph nodes. Eur J Radiol 2009;72(3):381-7.
22. King AD, Ahuja AT, Yeung DK, et al. Malignant cervical lymphadenopathy: diagnostic accuracy of diffusion-weighted MR imaging. Radiology 2007;245(3):806-13.
23. Vandecaveye V, De Keyzer F, Vander Poorten V, et al. Head and neck squamous cell carcinoma: value of diffusion-weighted MR imaging for nodal staging. Radiology 2009;251(1):134-46.
24. De Bondt RB, Hoeberigs MC, Nelemans PJ, et al. Diagnostic accuracy and additional value of diffusion-weighted imaging for discrimination of malignant cervical lymph nodes in head and neck squamous cell carcinoma. Neuroradiology 2009;51(3):183-92.
25. Musio D, Bulzonetti N, Maghella F, et al. Target volume delineation based on diffusion-weighted magnetic resonance imaging for locally advanced head and neck cancer. Anticancer Res 2016;36(8):4181-5.
26. Kauppinen RA, Peet AC Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: Preclinical and clinical approaches Cancer Biol Ther. 2011 Oct 15; 12(8): 665–679. doi: 10.4161/cbt.12.8.18137
27. Abdel Razek AA, Poptani H.MR spectroscopy of head and neck cancer.Eur J Radiol. 2013 Jun;82(6):982-9. doi: 10.1016/j.ejrad.2013.01.025.
28. Yeung DK, Fong KY, Chan QC, et al. Chemical shift imaging in the head and neck at 3T: initial results. J Magn Reson Imaging 2010;32(5):1248-54.
29. Yuan J, Chen S, King AD, et al. Amide proton transfer-weighted imaging of the head and neck at 3 T: a feasibility study on healthy human subjects and patients with head and neck cancer. NMR Biomed 2014;27(10):1239-47.
30. Wang J, Hwang K, Fuller C, et al. SU-E-J-225: CEST imaging in head and neck cancer patients. Med Phys 2015;42(6). 3317-3317
31. Bisdas S, Fetscher S, Feller AC, et al. Primary B cell lymphoma of the sphenoid sinus: CT and MRI characteristics with correlation to perfusion and spectroscopic imaging features. Eur Arch Otorhinolaryngol 2007;264(10):1207-13.
32. King AD, Yeung DK, Ahuja AT, et al. Human cervical lymphadenopathy: evaluation with in vivo 1 H-MRS at 1.5 T. Clin Radiol 2005;60(5):592-8.
33. Yu Q, Yang J, Wang P, et al. Preliminary assessment of benign maxillofacial and neck lesions with in vivo single-voxel 1 H magnetic resonance spectroscopy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007;104(2):264-70.
34. Galban CJ, Mukherji SK, Chenevert TL, et al. A feasibility study of parametric response map analysis of diffusion-weighted magnetic resonance imaging scans of head and neck cancer patients for providing early detection of therapeutic efficacy. Transl Oncol 2009;2(3):184-90.
35. Vandecaveye V, Dirix P, De Keyzer F, et al. Predictive value of diffusion weighted magnetic resonance imaging during chemoradiotherapy for head and neck squamous cell carcinoma. Eur Radiol 2010;20(7):1703-14.
36. Chen Y, Liu X, Zheng D, et al. Diffusion-weighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma. Magn Reson Imaging 2014;32(6):630-7.
37. Martins EB, Chojniak R, Kowalski LP, et al. Diffusion-weighted MRI in the assessment of early treatment response in patients with squamouscell carcinoma of the head and neck: comparison with morphological and PET/CT findings. PLoS One 2015;10(11):0140009.
38. Wong KH, Panek R, Welsh L, et al. The predictive value of early assessment after 1 cycle of induction chemotherapy with 18F-FDG PET/ CT and diffusion-weighted MRI for response to radical chemoradiotherapy in head and neck squamous cell carcinoma. J Nucl Med 2016;57(12):1843-50.
39. King AD, Chow KK, Yu KH, et al. Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response. Radiology 2013;266(2):5318.
40. King AD, Mo FK, Yu KH, et al. Squamous cell carcinoma of the head and neck: diffusion-weighted MR imaging for prediction and monitoring of treatment response. Eur Radiol 2010;20(9):2213-20.
41. Abdel Razek AA, Kandeel AY, Soliman N, et al. Role of diffusionweighted echo-planar MR imaging in differentiation of residual or recurrent head and neck tumors and posttreatment changes. AJNR Am J Neuroradiol 2007;28(6):1146-52.
42. King AD, Keung CK, Yu KH, et al. T2-weighted MR imaging early after chemoradiotherapy to evaluate treatment response in head and neck squamous cell carcinoma. AJNR Am J Neuroradiol 2013;34(6):1237-41.
Review
For citations:
Semenova M.D., Sokurenko V.P., Stanzhevskiy A.A., Mus V.F. DIFFUSION-WEIGHTED MRI AND PROTON MAGNETIC RESONANCE SPECTROSCOPY IN THE DIAGNOSIS AND EVALUATION OF THE EFFECTIVENESS OF CHEMORADIOTHERAPY OF HEAD AND NECK TUMORS (THE LITERATURE REVIEW). Translational Medicine. 2019;6(1):17-26. (In Russ.) https://doi.org/10.18705/2311-4495-2019-6-1-17-26
Views:
1006
Email this article 